Does TESAMORELIN Cause Neoplasm malignant? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Neoplasm malignant have been filed in association with TESAMORELIN (EGRIFTA SV). This represents 0.5% of all adverse event reports for TESAMORELIN.
12
Reports of Neoplasm malignant with TESAMORELIN
0.5%
of all TESAMORELIN reports
0
Deaths
2
Hospitalizations
How Dangerous Is Neoplasm malignant From TESAMORELIN?
Of the 12 reports, 2 (16.7%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TESAMORELIN. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TESAMORELIN Cause?
Product dose omission issue (277)
Arthralgia (188)
Injection site pain (186)
Incorrect dose administered (167)
Drug ineffective (159)
Weight increased (138)
Injection site bruising (134)
Peripheral swelling (126)
Pain in extremity (121)
Product preparation issue (119)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which TESAMORELIN Alternatives Have Lower Neoplasm malignant Risk?
TESAMORELIN vs TESTOSTERONE
TESAMORELIN vs TESTOSTERONE CYPIONATE
TESAMORELIN vs TESTOSTERONE ENANTHATE
TESAMORELIN vs TESTOSTERONE UNDECANOATE
TESAMORELIN vs TETANUS TOXOIDS